US Patent

US12433868 — Polymorphic forms of ST-246 and methods of preparation

Formulation · Assigned to Siga Technologies Inc · Expires 2031-03-23 · 5y remaining

Vulnerability score 61/100 Moderate — design-around opportunities exist

What this patent protects

This patent discloses polymorphic forms of ST-246 and their methods of preparation, as well as pharmaceutical compositions containing these forms.

USPTO Abstract

Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindo1-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number: US12433868
Jurisdiction: US
Classification: Formulation
Expires: 2031-03-23
Drug substance claim: No
Drug product claim: Yes
Assignee: Siga Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.